Reference
Naniwa T, et al. Long-term efficacy and safety of add-on tacrolimus for persistent, active rheumatoid arthritis despite treatment with methotrexate and tumor necrosis factor inhibitors. International Journal of Rheumatic Diseases 21: 673-687, No. 3, Mar 2018. Available from: URL: http://doi.org/10.1111/1756-185X.13248 - Japan
Rights and permissions
About this article
Cite this article
Infliximab. Reactions Weekly 1697, 200 (2018). https://doi.org/10.1007/s40278-018-44756-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-018-44756-y